ReP USP - Resultado da busca

Artigo de periodico
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys (2024)
Naveen, R ; Sen, Parikshit ; Griger, Zoltan; Day, Jessica ; Joshi, Mrudula; Nune, Arvind; Nikiphorou, Elena ; Saha, Sreoshy ; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki
Fonte: RHEUMATOLOGY. Unidade: FM
Assuntos: COVID-19, VACINAS, MIOSITE, COMORBIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAVEEN, R et al. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys. RHEUMATOLOGY, v. 63, n. 1, p. 127-139, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57851. Acesso em: 22 ago. 2024.
APA
Naveen, R., Sen, P., Griger, Z., Day, J., Joshi, M., Nune, A., et al. (2024). Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys. RHEUMATOLOGY, 63( 1), 127-139. doi:10.1093/rheumatology/kead180
NLM
Naveen R, Sen P, Griger Z, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys [Internet]. RHEUMATOLOGY. 2024 ; 63( 1): 127-139.[citado 2024 ago. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57851
Vancouver
Naveen R, Sen P, Griger Z, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys [Internet]. RHEUMATOLOGY. 2024 ; 63( 1): 127-139.[citado 2024 ago. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57851
Artigo de periodico
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study (2023)
Doskaliuk, Bohdana; Ravichandran, Naveen ; Sen, Parikshit ; Day, Jessica ; Joshi, Mrudula; Nune, Arvind; Nikiphorou, Elena ; Saha, Sreoshy ; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki
Fonte: Rheumatology international. Unidade: FM
Assuntos: VACINAÇÃO, COVID-19, MIOSITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOSKALIUK, Bohdana et al. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology international, v. 43, n. 9, p. 1651-1664, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/55968. Acesso em: 22 ago. 2024.
APA
Doskaliuk, B., Ravichandran, N., Sen, P., Day, J., Joshi, M., Nune, A., et al. (2023). Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology international, 43( 9), 1651-1664. doi:10.1007/s00296-023-05345-y
NLM
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology international. 2023 ; 43( 9): 1651-1664.[citado 2024 ago. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55968
Vancouver
Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study [Internet]. Rheumatology international. 2023 ; 43( 9): 1651-1664.[citado 2024 ago. 22 ] Available from: https://observatorio.fm.usp.br/handle/OPI/55968
Artigo de periodico
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies (2022)
Gil-Vila, Albert; Ravichandran, Naveen; Selva-O'callaghan, Albert; Sen, Parikshit; Nune, Arvind; Gaur, Prithvi Sanjeevkumar; Gonzalez, Raquel Aranega; Lilleker, James B; Joshi, Mrudula; Shinjo, Samuel Katsuyuki
Fonte: Muscle & nerve. Unidade: FM
Assuntos: COVID-19, DERMATOPATIAS, MIOSITE, REUMATOLOGIA, VACINAÇÃO, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIL-VILA, Albert et al. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle & nerve, v. 66, n. 4, p. 426-437, 2022Tradução . . Disponível em: https://doi.org/10.1002/mus.27681. Acesso em: 22 ago. 2024.
APA
Gil-Vila, A., Ravichandran, N., Selva-O'callaghan, A., Sen, P., Nune, A., Gaur, P. S., et al. (2022). COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies. Muscle & nerve, 66( 4), 426-437. doi:10.1002/mus.27681
NLM
Gil-Vila A, Ravichandran N, Selva-O'callaghan A, Sen P, Nune A, Gaur PS, Gonzalez RA, Lilleker JB, Joshi M, Shinjo SK. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies [Internet]. Muscle & nerve. 2022 ; 66( 4): 426-437.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1002/mus.27681
Vancouver
Gil-Vila A, Ravichandran N, Selva-O'callaghan A, Sen P, Nune A, Gaur PS, Gonzalez RA, Lilleker JB, Joshi M, Shinjo SK. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies [Internet]. Muscle & nerve. 2022 ; 66( 4): 426-437.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1002/mus.27681
Artigo de periodico
COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis (2022)
Faria, M. S. M. S; Shinjo, Samuel Katsuyuki
Fonte: Reumatismo. Unidade: FM
Assuntos: COVID-19, REUMATOLOGIA, MIOSITE, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIA, M. S. M. S e SHINJO, Samuel Katsuyuki. COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis. Reumatismo, v. 74, n. 1, p. 41-43, 2022Tradução . . Disponível em: https://doi.org/10.4081/reumatismo.2022.1440. Acesso em: 22 ago. 2024.
APA
Faria, M. S. M. S., & Shinjo, S. K. (2022). COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis. Reumatismo, 74( 1), 41-43. doi:10.4081/reumatismo.2022.1440
NLM
Faria MSMS, Shinjo SK. COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis [Internet]. Reumatismo. 2022 ; 74( 1): 41-43.[citado 2024 ago. 22 ] Available from: https://doi.org/10.4081/reumatismo.2022.1440
Vancouver
Faria MSMS, Shinjo SK. COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis [Internet]. Reumatismo. 2022 ; 74( 1): 41-43.[citado 2024 ago. 22 ] Available from: https://doi.org/10.4081/reumatismo.2022.1440
Artigo de periodico
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry (2022)
Yeoh, Su-Ann; Gianfrancesco, Milena; Lawson-Tovey, Saskia; Hyrich, Kimme L; Strangfeld, Anja; Gossec, Laure; Carmona, Loreto; Mateus, Elsa F; Schaefer, Martin; Shinjo, Samuel Katsuyuki
Fonte: Rmd open. Unidade: FM
Assuntos: COVID-19, MIOSITE, AVALIAÇÃO DE RESULTADOS (CUIDADOS DE SAÚDE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YEOH, Su-Ann et al. Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Rmd open, v. 8, n. 2, 2022Tradução . . Disponível em: https://doi.org/10.1136/rmdopen-2022-002508. Acesso em: 22 ago. 2024.
APA
Yeoh, S. -A., Gianfrancesco, M., Lawson-Tovey, S., Hyrich, K. L., Strangfeld, A., Gossec, L., et al. (2022). Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Rmd open, 8( 2). doi:10.1136/rmdopen-2022-002508
NLM
Yeoh S-A, Gianfrancesco M, Lawson-Tovey S, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Schaefer M, Shinjo SK. Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry [Internet]. Rmd open. 2022 ; 8( 2):[citado 2024 ago. 22 ] Available from: https://doi.org/10.1136/rmdopen-2022-002508
Vancouver
Yeoh S-A, Gianfrancesco M, Lawson-Tovey S, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Schaefer M, Shinjo SK. Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry [Internet]. Rmd open. 2022 ; 8( 2):[citado 2024 ago. 22 ] Available from: https://doi.org/10.1136/rmdopen-2022-002508

Unidades USP

ReP

Filtros

Autores

Assuntos

Agência de fomento

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos